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In amphibian development, muscle is specified in the dorsal lateral marginal zone (DLMZ) of the gastrula embryo. Two
critical events specify the formation of skeletal muscle: the expression of the myogenic transcription factor, XMyoD, and
the secretion of bone morphogenetic protein (BMP) antagonists by the adjacent Spemann organizer. Inhibition of BMP
signaling during early gastrula stages converts XMyoD protein into an instructive differentiation factor in the DLMZ. Yet,
the intracellular signaling factors connecting BMP antagonism and activation of XMyoD remain unknown. Our data show
that BMP antagonism induces the activity of mitogen-activated protein kinase (MAPK), and that the activity of MAPK is
necessary for muscle-specific differentiation. Treatment of gastrula-stage DLMZ explants with MAPK pathway inhibitors
ventralized mesoderm and prevented muscle differentiation. Expression of XMyoD in ventral mesoderm weakly induced
muscle formation; however, the coexpression of a constitutively active MEK1 with XMyoD efficiently induced muscle
differentiation. Activation of the MAPK pathway did not induce the transcription of XMyoD, but increased its protein levels
and transcriptional activity. Thus, MAPK activation is subsequent to BMP antagonism, and participates in the dorsalization
of mesoderm by converting the XMyoD protein into a potent differentiation factor. © 2001 Academic Press
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Muscle is one of the first mesodermal tissues to be
induced in the developing vertebrate embryo. In Xenopus
laevis, muscle differentiates from cells located in the
dorsal–lateral region of the marginal zone. Initially, dorsal–
lateral marginal zone (DLMZ) tissue is ventrally fated. This
region is not specified for muscle and it will not differenti-
ate as muscle if removed from the embryo prior to gastru-
lation for explant culture (Dale and Slack, 1987). During
gastrulation, “dorsalizing” signals are secreted from the
adjacent dorsal marginal zone, the Spemann organizer re-
gion (reviewed in Harland and Gerhart, 1997). The organizer
expresses a number of secreted bone morphogenetic protein
(BMP) antagonist proteins such as noggin, chordin, and
follistatin (Smith et al., 1993; Lamb et al., 1994; Hemmati-
rivanlou et al., 1994; Sasai et al., 1994). Dorsalization of
the ventrally fated DLMZ to muscle requires inhibition of
endogenous BMP signaling in the DLMZ region by these
antagonist molecules (Sasai et al., 1995; Re’em-Kalma et
1 To whom correspondence may be addressed. Fax: 1972 (48)
553-299. E-mail: dale@tx.technion.ac.il or bengal@tx.technion.pac.il.
168l., 1995; Zimmerman et al., 1996; Piccolo et al., 1996).
hus, during early development, muscle arises through a
ultistep inductive process in which muscle cell fate is
pecified in the dorsal–lateral mesoderm region of the
mbryo.
The MyoD gene belongs to an extended family of muscle-
pecific basic helix–loop–helix DNA-binding proteins
hich commit cells to myogenic lineages (reviewed in
olkentin and Olson, 1996). In both vertebrates and inver-
ebrates, MyoD protein has been shown to play a critical
ole in muscle cell differentiation (reviewed in Weintraub et
l., 1991; Arnold and Winter 1998; Abmayr and Keller,
998). In Xenopus, ectopic expression of Xenopus MyoD
XMyoD) RNA in naive ectoderm induces transient expres-
ion of muscle markers without leading to a terminal
ommitment of these cells to muscle cell fates (Hopwood
nd Gurdon, 1990). XMyoD is initially expressed in all of
he ventral mesoderm during blastula to gastrula stages
Frank and Harland, 1991; Hopwood et al., 1992). However,
y the end of gastrulation, XMyoD expression becomes
xed in the DLMZ mesoderm fated to differentiate as
araxial somite tissue (Frank and Harland, 1991). This
bservation suggests that some aspect of the dorsalizing
rocess is required to maintain XMyoD expression in the
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169Conversion of MyoD in Xenopusmuscle-fated DLMZ, while expression is extinguished in
the ventral marginal zone (VMZ) region. In addition, it is
not clear why ectopic ventral XMyoD expression does not
commit cells to the myogenic lineage. It has been proposed
that signals leading to XMyoD autocatalytic transcriptional
ctivation are required for the maintenance of XMyoD
xpression in the presumptive somite region in the frog
Lun et al., 1997; Steinbach et al., 1998). Differential
nuclear localization may also play a role in the ability of
XMyoD protein to commit cells to myogenic cell fates
(Rupp et al., 1994).
In Xenopus, little is known about the signals which
positively regulate XMyoD expression and protein activity
in the DLMZ. BMP antagonists induce muscle differentia-
tion and XMyoD expression in VMZ explants. However, the
chain of signaling events leading to the activation of
XMyoD protein as an instructive differentiation factor is
poorly understood. In mammalian cell culture, attempts
have been made to address the question of signaling path-
ways which interact with MyoD to direct myogenesis. In
cultured mouse C2 myoblast cells, the activity of mitogen-
activated protein kinase (MAPK) or extracellular regulated
kinase (ERK) increased during myogenesis (Gredinger et al.,
1998). MAPK activity was required for terminal differentia-
tion (Gredinger et al., 1998). MAPK positively regulated the
expression and activity of MyoD protein in mouse C2
myoblast cells, suggesting that MAPK signaling could play
an early role in the conversion of MyoD to an instructive
differentiation factor (Gredinger et al., 1998).
In this study, we have examined the role of MAPK
signaling in the muscle-specification process in Xenopus.
We found that inhibition of BMP activity stimulated MAPK
activity in dorsalized VMZ explants. During gastrula to
neurula stages, MAPK activity in DLMZ explants is high
relative to VMZ explants. Dorsalized VMZ and DLMZ
explants treated with MAPK pathway inhibitors did not
differentiate as muscle and maintained ventral mesoderm
identity. Coectopic expression of activated MAP kinase
kinase (MEK) and XMyoD RNAs induced muscle actin
expression, cell-movement elongations, and terminal differ-
entiation in VMZ explants. In VMZ explants, coectopic
expression of activated MEK and XMyoD stimulated the
ability of XMyoD to transcriptionally activate an E-box-
dependent reporter gene. In these explants, the amount of
XMyoD protein was increased and it appeared localized to
the nucleus. These results suggest that BMP antagonists
activate the MAPK cascade in the DLMZ, and that MAPK
activation is required to convert XMyoD into a terminal
differentiation factor.
MATERIALS AND METHODS
Xenopus Embryos, Explants, and RNA
Microinjection
Ovulation, in vitro fertilization, embryo culture, and dissections
were carried out as described in Re’em-Kalma et al. (1995). Em-
ryos were staged according to Nieuwkoop and Faber (1967).
Copyright © 2001 by Academic Press. All rightarious synthetic RNA or DNA were injected into embryos at the
ne-cell stage. Capped synthetic Xenopus BMP dominant-negative
DN) receptor RNA (0.1 or 0.4 ng) was injected into the marginal
one (Graff et al., 1994). Capped synthetic Xenopus MyoD RNA
(pSP64T-XMyoD; Hopwood and Gurdon, 1990) was injected at a
concentration of 2 ng/embryo. RNA encoding the constitutively
active MEK (MEK1S217E/S221E; Umbhauer et al., 1995) protein
was injected at a concentration 2.5 or 5 ng/embryo. Plasmid
containing the 4R-tk-Luciferase reporter gene (gift of Dr. Stephen
apscott) was injected at a concentration of 50 pg/embryo. Ventral
arginal zone (VMZ) and dorsal–lateral marginal zone (DLMZ)
xplants were removed at stage 10–10.25, and cultured to different
tages as described in Bonstein et al. (1998). In some experiments,
explants were treated with the MEK inhibitors: PD098059 (50 mM)
nd UO126 (20 and 50 mM) (Calbiochem).
Western Blot Analysis
To prepare cell extracts, explants were washed in PBS and lysed
(9 explants in 20 ml lysis buffer). Lysis buffer contains 25 mM Hepes
(pH 7.7), 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1% Triton
-100, 0.5 mM dithiothreitol, 1 mM Na3VO4, 10 mg/ml leupeptin,
.7 mg/ml aprotinine, 100 mg/ml phenylmethylsulfonyl fluoride, 1
mM glycerolphosphate, and 20 mM p-nitrophenyl phosphate. The
extract was cleared by three centrifugations at 12,000g for 5 min.
Protein concentration was determined by the Bio-Rad protein
assay. Equal amounts of extracted proteins were loaded (approxi-
mately 30 mg), separated by SDS–polyacrylamide gel electrophore-
sis, and transferred to nitrocellulose filters.
ERK MAPK Western blot analysis was performed by using the
Phospho-Plus p44/p42 MAPK antibody kit (Cell Signaling–New
England Biolabs). XMyoD Western blot analysis was performed by
using the supernatant of D7F2 hybridoma (Hopwood et al., 1992),
diluted 1:2.5 in blocking solution. Proteins were visualized by
using the enhanced chemiluminescence kit (Pierce).
Luciferase Assay
Extract preparation and luciferase assay were performed by using
the Luciferase Assay System (Promega). Explants were lysed in the
lysis buffer (1 explant in 3 ml of lysis buffer). The luciferase activity
in the lysates was measured by integrating total light emission over
30 s with a Berthold luminometer. The luciferase activity was
normalized to total protein concentration.
Immunohistochemistry
Embryos were derived from fertilization of albino eggs (except
Fig. 4D, wild-type eggs) with wild-type sperm. Immunostaining
was performed as described by Hemmati-Brivanlou and Harland
(1989). Tissue culture supernatant of D7F2 hybridoma (anti-
XMyoD; Hopwood et al., 1992) was used undiluted. Tissue culture
upernatant of 12/101 (mature muscle antigen; Kintner and
rockes, 1984) was diluted 1:1. Bound antibodies were detected
ith HRP-conjugated secondary antibodies (goat anti-mouse IgG;
ierce) diluted 1:100, and were visualized with the HRP color-
eveloping reagent (DAB substrate; Amresco). After fixing the
tain, some embryos were cleared in 1:2 benzyl alcohol/benzyl
enzoate (Hemmati-Brivanlou and Harland, 1989).
Northern Blot Analysis and RT-PCR
RNA was extracted from embryos and prepared for Northernblot analysis as described in Re’em-Kalma et al. (1995). Electro-
s of reproduction in any form reserved.
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170 Zetser, Frank, and Bengalphoresis, probe preparation, filter hybridization, and exposure were
performed as described in Re’em-Kalma et al. (1995). Quantitation
was performed by using a Fuji phosphorimaging system. EF1a was
used as a positive standard for comparing amounts of RNA loaded
per well at any given stage.
RT-PCR was performed as described in Wilson and Melton
(1994), except that random hexamers (100 ng per reaction) were
used for reverse transcription. Primers for EF1a were described in
Hemmati-Brivanlou and Melton (1994). Primers for XMyoD were
described in Nicolas et al. (1998). Primers for Muscle Actin were
escribed in Wilson and Melton (1994).
RESULTS
Accumulation of High Levels of Phosphorylated
ERK in the Dorsal–Lateral Marginal Zone Occurs
during the Activation of XMyoD Expression
To study the possibility that the MAPK pathway was
involved in the early development of skeletal muscle, we
compared the levels of phosphorylated ERK in the ventral
marginal zone (VMZ) and the dorsal–lateral marginal zone
(DLMZ) during gastrula and neurula stages. Explants of
VMZ and DLMZ were dissected at early gastrula stages (st.
101–10.25), and cultured until sibling embryos reached
later gastrula and neurula stages. Protein was extracted
from explants and ERK was detected by Western blotting
(Fig. 1A). Levels of phosphorylated ERK were high at early
and late gastrula stages (sts. 10.5 and 12), and were hardly
detected at late neurula stages in DLMZ explants. At
gastrula stages, the absolute amount of phosphorylated ERK
was significantly higher in DLMZ explants than in VMZ
explants (Fig. 1, compare lanes 1 and 2 to lanes 5 and 6).
Using an in vitro kinase assay to measure MBP protein
hosphorylation (Gredinger et al., 1998), we also deter-
ined that ERK activity was significantly higher in DLMZ
ersus VMZ explant extracts (not shown). The activation of
MyoD transcription occurs during gastrula stages (Hop-
ood et al., 1989). Therefore, the initial expression of
MyoD occurred during gastrula stages when ERK activity
as highest. Expression of later terminal differentiation
arkers such as muscle actin can be detected at late
eurula stages; levels of phosphorylated ERK were greatly
educed at these stages (Fig. 1A, lane 7). In conclusion, the
orsal–lateral mesoderm is characterized by high levels of
ctive ERK during the early stages of XMyoD expression.
Inhibition of BMP Signaling Induces ERK
Phosphorylation and Skeletal Muscle
Differentiation
It was previously demonstrated that inhibition of BMP
signaling in ventral mesoderm changed its fate to a more
dorsal mesoderm, that subsequently differentiated into
skeletal muscle (Smith et al., 1993; Graff et al., 1994). We
thought that if high MAPK activity plays an essential role
in muscle development, then inhibition of BMP signaling in
the VMZ might induce MAPK activity as part of the
differentiation process. Embryos were injected with a BMP
Copyright © 2001 by Academic Press. All rightDN receptor that blocks BMP signaling in cells expressing
this mutated receptor (Graff et al., 1994). VMZ explants
were isolated at early gastrula stages, and cultured until
sibling embryos reached stage 12. Phosphorylated ERK was
barely detectable in control VMZ explants of uninjected
embryos (Fig. 1B, lane 1). VMZ explants dorsalized by
injection with the BMP DN receptor expressed high levels
of phosphorylated ERK in a dose-dependent manner (Fig.
1B, lanes 2 and 3). Similarly, injection of a constitutively
active form of MAP kinase kinase/MEK1 (Umbhauer et al.,
1995; MEK1S217E/S221E) into embryos induced phosphor-
ylation of ERK in a dose-dependent manner in VMZ ex-
plants (lanes 4 and 5). As expected, injection of the BMP DN
receptor induced the expression of muscle actin in VMZ
explants that were analyzed at neurula stage 15, whereas
similar explants from uninjected embryos did not express
muscle actin (Fig. 1C, compare lanes 1 and 3). Interestingly,
if the injected explants were treated with a specific inhibi-
tor of MEK1, PD098059, during their culture from st.
101–10.25 to st. 15, the expression of muscle actin was
ighly inhibited (Fig. 1C, compare lanes 3 and 4). Overall,
hese results indicate that inhibition of BMP signaling
nduces the MAPK pathway as part of the program of
keletal muscle development.
Inhibition of the MAPK Pathway during
Gastrulation Prevents the Formation
of Skeletal Muscle
To explore whether the activity of the MAPK pathway
was essential for myogenesis, DLMZ explants were isolated
at early gastrula stages and cultured in the presence of
PD098059 (Fig. 2A) or UO126 (Fig. 2B), specific pharmaco-
logical inhibitors of MEKs. Control DLMZ explants were
dissected from the same embryos and were grown in the
absence of these inhibitors. All explants were cultured until
sibling embryos reached different gastrula and neurula
stages. The expression of muscle actin was detected at late
neurula stage by Northern analysis (Figs. 2A and 2B, left).
At this stage, we observed high expression of muscle actin
in control explants, which was markedly inhibited in ex-
plants that were treated with each of the MEK inhibitors
(Figs. 2A and 2B, left). Both inhibitors prevented the phos-
phorylation of ERK in explants grown to stage 12 (data not
shown).
MAPK is required for the proper establishment of meso-
derm during early Xenopus development (Umbhauer et al.,
1995; LaBonne et al., 1995; Gotoh et al., 1995). Functional
MAPK signaling is prerequisite for proper XBra expression,
nd in the absence of proper XBra activity, mesoderm
ormation is severely inhibited (Conlon et al., 1996; Smith,
001). Therefore, inhibition of the MAPK pathway during
arly gastrula stages could have caused mesoderm dediffer-
ntiation. For that reason, we analyzed expression of the
esoderm-specific marker XBra during later gastrula
stages, in explants treated with MAPK kinase (MEK) inhibi-
tors (Figs. 2A and 2B, right). In comparison to controls,
similar levels of XBra transcripts were observed in the
s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightexplants that were treated with MEK inhibitors, suggesting
that inhibition of the MAPK pathway during gastrula stages
did not affect mesoderm identity in explants. However,
analysis of the expression of XVent1 (not shown) and
XVent2 (Figs. 2A and 2B, right) indicated that their expres-
sion was increased in explants that were treated with MEK
inhibitors relative to control explants. These markers are
expressed during gastrula stages in the ventral mesoderm
(Gawantka et al., 1995; Papalopulu and Kintner, 1996;
Schmidt et al., 1996; Onichtchouk et al., 1996). Hence, we
an conclude that inhibition of the MAPK pathway during
astrula stages changes dorsal mesoderm to a more ventral
ate, that during normal development is not a precursor of
keletal muscle differentiation.
To further validate that inhibition of the MAPK pathway
epressed skeletal muscle differentiation, we analyzed the
longation of explants which is a characteristic of muscle
evelopment. DLMZ explants were elongated as expected,
hile the number of elongated explants was reduced with
ncreased concentrations of the MEK inhibitor, UO126 (Fig.
C). Explants were also stained for the 12/101 antigen, a
arker of terminal muscle differentiation (Kintner and
rockes, 1984). Muscle was stained in well-defined blocks
n control DLMZ explants (Fig. 2D). Treatment of explants
ith UO126 caused a significantly reduced staining of
uscle. The specificity of the antibody was shown by the
omitic staining of a whole embryo from the same devel-
pmental stage (Fig. 2D, right).
Activation of MAPK in Ventral Mesoderm Induces
the Formation of Skeletal Muscle
To further explore the role of MAPK in myogenesis, we
injected an RNA encoding a constitutively active form of
MEK1 (MEK1S217E/S221E) and/or RNA encoding the
XMyoD protein into fertilized eggs. Blastula (st. 8–9) ani-
mal cap and early gastrula (st. 10–10.25) VMZ explants
were cultured until sibling embryos reached late neurula
transcribed Xenopus BMP DN receptor RNA, or with either 2.5 or
5 ng of in vitro transcribed constitutively active form of MEK1 (Act
MEK1) RNA. VMZ explants were removed at stage 101–10.25 and
cultured until sibling embryos reached stage 12. Protein was
isolated from each treatment group (14 explants) for Western blot
analysis using the New England Biolabs PhosphoPlus p44/p42
MAPK Antibody Kit. (C) Embryos at the one-cell stage were
injected with 0.4 ng of in vitro transcribed Xenopus BMP DN
eceptor RNA. Thirty VMZ explants were removed from unin-
ected and injected embryos. Fifteen explants from each group were
rown with (lane 4) or without (lane 3) 50 mM PD098059. Total
NA was isolated from pools of 15 neurula stage-15 VMZ explants
rom each treatment. All VMZ RNA was loaded per well for
orthern analysis. One embryo equivalent of RNA was loaded
lane 5). The filter was sequentially hybridized with Xenopus
DNA probes for muscle-specific actin (mActin) and EF1a. EF1a
served as a positive control for quantitating RNA levels in theFIG. 1. BMP antagonism induces phosphorylation of ERK in the
ventral marginal zone (VMZ). Dorsalization of the VMZ to muscle
by BMP antagonism is dependent on MAPK activity. (A) Extracts
from nine DLMZ or VMZ explants were separated by SDS–PAGE,
Western blotted, and sequentially probed with a polyclonal anti-
body specific for phosphorylated ERK and with a polyclonal anti-
body specific for total ERK protein (New England Biolabs Phos-
phoPlus p44/p42 MAPK Antibody Kit). Phosphorylated p42 was
used as a positive control (lane 9). Lanes are labeled according to the
developmental stages (Nieuwkoop and Faber, 1967). (B) Embryos atdifferent samples.
s of reproduction in any form reserved.
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173Conversion of MyoD in Xenopusstages, and muscle actin expression was determined by
Northern analysis (Fig. 3A). The active form of MEK1 did
not induce expression of muscle actin in animal cap and
VMZ explants (Fig. 3A, lanes 2 and 6), whereas XMyoD
induced some expression of muscle actin in the VMZ (Fig.
3A, lane 7). Injection of RNA molecules encoding XMyoD
and active MEK1 induced strong expression of muscle actin
in the VMZ (Fig. 3A, lane 8), and weaker expression in
animal cap explants (Fig. 3A, lane 4). Therefore, it appears
that XMyoD and activated MEK1 cooperate in the induc-
tion of muscle actin expression. We also analyzed the
expression of muscle actin in animal caps by RT-PCR (Fig.
B). Active MEK1 did not induce any muscle actin expres-
ion (Fig. 3B, lane 2), XMyoD induced its weak expression
Fig. 3B, lane 3), and both molecules induced a significantly
igher expression of muscle actin (Fig. 3B, lane 4). From the
evels of injected RNA encoding XMyoD, we can conclude
hat the increase in muscle actin expression was not due to
ifferent amounts of XMyoD transcripts (Fig. 3B, compare
anes 3 and 4). The synergism between XMyoD and active
EK1 was further assessed by analyzing explant elongation
Fig. 3C), and the expression of muscle antigen recognized
y the 12/101 monoclonal antibody (Fig. 3D). By both
riteria, XMyoD induced some skeletal muscle differentia-
ion in VMZ explants; however, the combination of
MyoD and active MEK1 enhanced significantly the
uscle phenotype (Figs. 3C and 3D).
Activation of MAPK Does Not Induce Expression
of XMyoD in VMZ Explants
We observed that the inhibition of BMP signaling induced
ERK activity (Fig. 1B), and the expression of muscle actin
(Fig. 1C). Still, the direct activation of MAPK by ectopic
MEK expression was not sufficient to activate the expres-
sion of muscle actin (Figs. 3A and 3B).
To further elucidate the different effects induced by BMP
nhibition and MAPK activation, we injected embryos with
NA encoding an activated MEK1 protein or the BMP DN
eceptor. The expression of XMyoD was analyzed by RT-
PCR in VMZ explants grown until at stage 14 (Fig. 4). The
FIG. 2. Prevention of skeletal muscle formation by inhibition of
removed at stage 101–10.25. Eighteen explants were cultured in th
left) or stage 11 (right). Eighteen untreated explants served as contro
ll DLMZ explant RNA and one embryo equivalent of RNA were lo
ybridized with Xenopus cDNA probes for mActin and EF1a. The
for Xbra, Vent2, and EF1a. EF1a served as a positive control for q
explants were removed at stage 101–10.25 and cultured in the pre
stage 11 (right). Eighteen untreated explants served as controls. To
All the DLMZ RNA and one embryo equivalent of RNA were load
hybridized with Xenopus cDNA probes for mActin and EF1a. The
for Xbra, Vent2, and EF1a. EF1a served as a positive control for qua
removed at stage 101–10.25 and cultured without or in the presence
ere examined for elongation. (D) DLMZ explants from albino em
O126; embryos were stained with the muscle-specific 12/101 monocl
Copyright © 2001 by Academic Press. All rightBMP DN receptor induced the expression of endogenous
transcripts of XMyoD, while active MEK1 did not (Fig. 4).
Therefore, in addition to its function in inducing MAPK
activity, the BMP DN receptor could independently cause
the accumulation of XMyoD transcripts. Activation of
MAPK only, was not sufficient to induce expression of
XMyoD transcripts.
MAPK Induces Accumulation and Activity of
XMyoD Protein
Although MAPK signaling cannot initiate the expression
of XMyoD, it might affect the activity of preexisting
XMyoD protein. To analyze this possibility, we studied
how MAPK affected the transcriptional activity of XMyoD.
For that, we injected a MyoD-responsive reporter gene
(4R-tk-Luc), and RNA encoding MyoD and/or active MEK1
proteins into one-cell embryos. Luciferase activity was
measured in VMZ explants grown to stage 12 (Fig. 5A).
XMyoD significantly induced the activity of the reporter
gene over the background levels of the VMZ explants (Fig.
5A, compare lanes 1 and 3). Active MEK1 did not effect the
transcription of the reporter gene (Fig. 5A, lane 2), however,
a combination of XMyoD and active MEK1 induced tran-
scription in a cooperative manner (Fig. 5A, compare lanes
2–4). To analyze how the inhibition of the MAPK pathway
affected the activity of XMyoD, we measured luciferase
activity in DLMZ explants that were treated with UO126
(Fig. 5B). Injection of an RNA molecule encoding XMyoD
significantly induced the activity of the reporter gene (Fig.
5B, compare lanes 1 and 3). Addition of UO126 to the
injected explants inhibited reporter activity by about two-
fold (Fig. 5B, compare lanes 3 and 4). These results suggest
that the MAPK pathway induces the transcriptional activ-
ity of XMyoD.
To continue and explore the possible reason for XMyoD-
modified activity, we analyzed the levels of injected RNA
encoding XMyoD by RT-PCR (Fig. 6A, right). The levels of
XMyoD transcripts appeared equal in all the injected ex-
plants, suggesting that the amounts of ectopic XMyoD
transcripts could not account for the differences in XMyoD
activity during gastrulation. (A) Thirty-six DLMZ explants were
sence of 50 mM PD098059 until sibling embryos reached stage 19
otal RNA was isolated from pools of nine explants from each group.
per well for Northern analysis. The stage-19 filter was sequentially
-11 filter was sequentially hybridized with Xenopus cDNA probes
itating RNA levels in the different samples. (B) Thirty-six DLMZ
e of 20 mM UO126 until sibling embryos reached stage 19 (left) or
NA was isolated from pools of nine explants from each treatment.
er well for Northern analysis. The stage-19 filter was sequentially
-11 filter was sequentially hybridized with Xenopus cDNA probes
ting RNA levels in the different samples. (C) DLMZ explants were
0 or 50 mM UO126 until sibling embryos reached stage 18. Explants
were cultured until stage 27 without or in the presence of 20 mMMEK
e pre
ls. T
aded
stage
uant
senc
tal R
ed p
stage
ntita
of 2
bryos
onal antibody.
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175Conversion of MyoD in Xenopusactivity, as presented in Fig. 5. Next, we analyzed the
protein levels of MyoD using protein extracts from the
same experiment (Fig. 6A, left). We found that XMyoD
protein levels were reduced in VMZ and DLMZ explants
treated with UO126, relative to control untreated explants
(Fig. 6A, left). To further investigate the possibility that
MAPK affected XMyoD protein levels, a complementary
experiment that tested the effect of the activation of MAPK
was performed (Fig. 6B). XMyoD protein levels were com-
FIG. 4. Activation of MAPK does not induce XMyoD expression
n VMZ explants. Embryos at the one-cell stage were injected with
.4 ng of in vitro transcribed Xenopus BMP DN receptor RNA or
ith 2.5 ng of the constitutively active form of MEK1 (Act MEK1)
NA. At stage 10.25, 18 VMZ explants were removed from each
njected or uninjected embryo group. Explants were grown until
ibling embryos reached stage 14, and total RNA was isolated.
T-PCR analysis was performed with the markers XMyoD,
Actin, and EF1a. EF1a served as a positive control for quantitat-
ng RNA levels in the different samples. For controls, RT-PCR and
RT-PCR were performed on total RNA isolated from normal
mbryos.
FIG. 3. Ectopic expression of a constitutively active form of MEK
tage were injected with 2 ng of in vitro transcribed XMyoD RNA
EK1 (Act MEK1) RNA. VMZ explants removed at stage 101–10.
ibling embryos reached stage 20. Total RNA was isolated from ea
ll explant RNA and one embryo equivalent of RNA were loaded
ith Xenopus cDNA probes for mActin and EF1a. EF1a served as
B) Embryos at the one-cell stage were injected with 2 ng of in vit
onstitutively active form of MEK1 (Act MEK1) RNA. Twenty
lastula-stage embryos. Explants from each group were grown to sta
he markers XMyoD, mActin, and EF1a. EF1a served as a positive co
RT-PCR and 2RT-PCR were performed on total RNA isolated from
2 ng of in vitro transcribed XMyoD RNA or/and with 2.5 ng of in v
t stage 101–10.25, 16–30 VMZ explants were removed from each
mbryos reached stage 18, when they were examined for elongation
tage 35 and stained with the muscle-specific 12/101 monoclonal antib
Copyright © 2001 by Academic Press. All rightared between VMZ explants that expressed injected
MyoD and those that expressed injected XMyoD and
ctive MEK1. Levels of XMyoD protein were significantly
igher in the second group of explants (Fig. 6B, left),
lthough the levels of injected RNA encoding XMyoD were
imilar between the two groups (Fig. 6B, right). All the
bove experiments were analyzed at stage 12, the time
hen endogenous levels of XMyoD are induced, and the
APK pathway is activated in the dorsal–lateral meso-
erm.
Collectively, these results suggest that activity of the
APK pathway affects a posttranscriptional event regulat-
ng the accumulation of XMyoD protein. A previous study
uggested that, during the transient expression of XMyoD
n the VMZ, XMyoD protein was localized to the cytoplasm
Rupp et al., 1994). To analyze whether the cellular distri-
ution of XMyoD protein was affected by the MAPK
athway, we immunostained XMyoD-injected DLMZ ex-
lants that were incubated in the presence or absence of
O126 with the D7F2 XMyoD monoclonal antibody (Hop-
ood et al., 1992). Punctate staining of XMyoD was de-
ected in DLMZ explants in contrast to UO126-treated
xplants (Fig. 7, upper/lower left). At higher magnification,
trong nuclear localization was observed in control DLMZ
xplants versus the UO126-treated explants (Fig. 7, upper/
ower right). This staining confirms results presented in Fig.
, suggesting that the level of XMyoD protein was reduced
n UO126-treated cells. However, we could not unequivo-
ally show that this reduction in protein levels is the direct
ause of differential cytoplasmic–nuclear localization.
DISCUSSION
In Xenopus embryos, dorsal–lateral mesoderm is speci-
fied to muscle during gastrulation by inductive signals
emanating from the Spemann organizer (reviewed in Har-
land and Gerhart, 1997). Juxtaposed organizer cells secrete
BMP antagonists such as noggin, follistatin, and chordin
which recruit these ventrally fated cells to more dorsal fates
hances muscle formation in the VMZ. (A) Embryos at the one-cell
d with 2.5 ng of in vitro transcribed constitutively active form of
nd animal cap explants removed at stage 8–9, were cultured until
roup of explants (15 explants per group) and from whole embryos.
well for Northern analysis. The filter was sequentially hybridized
itive control for quantitating RNA levels in the different samples.
anscribed XMyoD RNA or/and with 2.5 ng of in vitro transcribed
al caps were removed from uninjected and injected groups of
and total RNA was isolated. RT-PCR analysis was performed with
l for quantitating RNA levels in the different samples. For controls,
mal embryos. (C) Embryos at the one-cell stage were injected with
transcribed constitutively active form of MEK1 (Act MEK1) RNA.
ted or uninjected embryo group. Explants were grown until sibling
The same embryos and VMZ explants (see Fig. 3C) were grown to1 en
or/an
25, a
ch g
per
a pos
ro tr
anim
ge 19
ntro
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injec
. (D)ody, that recognizes mature skeletal muscle.
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Copyright © 2001 by Academic Press. All rightsuch as muscle (Harland and Gerhart, 1997). These extra-
cellular signals act in concert with intracellular transcrip-
tion regulators to establish cell fate in the embryo. The
MyoD family of transcription factors is crucial in the
muscle-specification process. In both cell culture and ani-
mal model systems, members of the MyoD family have
been shown to be obligatory for the proper specification and
differentiation of muscle tissue (reviewed in Weintraub et
al., 1991; Arnold and Winter, 1998; Abmayr and Keller,
1998).
In early Xenopus development, the MyoD gene undergoes
a number of expression waves. Initially, the gene is ex-
pressed as a maternal transcript in the whole embryo
(Harvey, 1990; Rupp and Weintraub, 1991). At the onset of
zygotic transcription at the midblastula transition, MyoD is
ubiquitously expressed at low levels throughout the em-
bryo (Rupp and Weintraub, 1991; Harvey, 1991). Subse-
quently, high levels of induced zygotic transcripts and
protein accumulate in all of the nonorganizer mesoderm
during early–late gastrula stages (Frank and Harland, 1991;
Hopwood et al., 1992). Only as a result of the dorsalization
process does MyoD transcription become fixed in the
dorsal–lateral mesoderm fated for muscle (Frank and Har-
land, 1991). The question of how MyoD does not convert all
the ventral nonorganizer mesoderm to muscle is still unan-
swered. In addition, it is also unclear as to how the
dorsalization process fixes MyoD expression and converts
MyoD protein into an instructive differentiation factor in
the dorsal–lateral mesoderm.
In this study, we show that BMP antagonism in the VMZ
activates high transient levels of MAP kinase (ERK) activity
during gastrulation. MAPK activity is required for muscle
to be specified in the DLMZ by BMP antagonism; in the
presence of MAPK pathway inhibitors, BMP antagonism
will not dorsalize DLMZ tissue to muscle. However, MAPK
inhibition does not cause mesoderm dedifferentiation and a
loss of mesoderm specification. A number of studies have
shown that FGF signaling through the MAP kinase cascade
activates Xenopus Brachyury (XBra) gene transcription
(Umbhauer et al., 1995; LaBonne et al., 1995; Gotoh et al.,
1995). Expression of the XBra protein is a prerequisite for
proper mesoderm induction (reviewed in Smith, 2001).
Inhibition of MAPK activity in early gastrula-stage DLMZ
explants did not perturb XBra expression in these explants.
In addition, MAPK inhibition appeared to respecify the
DLMZ to a more ventral character, since expression of the
XVent1 and XVent2 markers was increased in DLMZ ex-
plants treated with MAPK pathway inhibitors. Increased
levels of eFGF expression (Standley et al., 2001) and MAPK
activity (Curran and Grainger, 2000) have been detected in
gastrula-stage dorsal mesoderm. eFGF has also been shown
to mediate the community effect in Xenopus myogenesis
(Standley et al., 2001). Future experiments should deter-
mine whether BMP antagonism in the DLMZ indeed acti-
vates MAP kinase through eFGF signaling.
These results suggest that, in addition to a primary phaseFIG. 5. Induction of XMyoD transcriptional activity by MAPK.
(A) Embryos at the one-cell stage were injected with 2 ng of in
vitro transcribed XMyoD RNA or/and with 2.5 ng of in vitro
ranscribed constitutively active form of MEK1 (Act MEK1)
NA. All embryos were injected with 50 pg of the E-Box-
ependent reporter gene plasmid, 4R-tk-Luc. At stage 101–
0.25, 27 VMZ explants were removed from each injected
mbryo group. Explants were grown until sibling embryos
eached stage 12. Protein extracts were examined for luciferase
ctivity. One representative experiment is shown; experiments
ere performed four times. (B) Embryos at the one-cell stage
ere injected with 50 ng of the previously mentioned reporter
lasmid (Fig. 5A). Embryos were injected with 2 ng of in vitro
ranscribed XMyoD RNA. At stage 101–10.25, 27 DLMZ ex-
lants were removed from the injected and control embryo
roups. Half of the explants were cultured in the presence of 50
mM UO126 until sibling embryos reached stage 12. Protein
xtracts were examined for luciferase activity. One representa-
ive experiment is shown; experiments were performed fourof MAPK activity regulating early mesoderm formation,
s of reproduction in any form reserved.
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177Conversion of MyoD in XenopusFIG. 6. Activation of MAPK increases XMyoD protein levels. (A) Protein extracts (9 explant equivalents), as described in Fig. 5B, were
separated by SDS–PAGE, Western blotted, and sequentially probed with the XMyoD-specific D7F2 monoclonal antibody and with a
polyclonal antibody specific for total ERK protein (left). Total ERK protein served as a positive control for quantitating protein levels in the
different samples. A portion of the same extract was also used for total RNA preparation. RT-PCR analysis was performed with the markers
XMyoD and EF1a (right). EF1a served as a positive control for quantitating RNA levels in the different samples. For controls, RT-PCR and
RT-PCR were performed on total RNA isolated from normal embryos. (B) Protein extracts (9 explant equivalents), as described in Fig. 5A,
ere separated by SDS–PAGE, Western blotted, and sequentially probed with the XMyoD-specific D7F2 monoclonal antibody and with a
olyclonal antibody specific for total ERK protein (left). Total ERK protein served as a positive control for quantitating protein levels in the
ifferent samples. A portion of the same extract was used for total RNA preparation. RT-PCR analysis was performed with the markers
MyoD and EF1a (right). EF1a served as a positive control for quantitating RNA levels in the different samples. For controls, RT-PCR and
RT-PCR were performed on total RNA isolated from normal embryos.
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required for the specification of mesoderm to more dorsal
fates by BMP antagonists. Experiments in Xenopus animal
ap explants have also shown induction of MAPK activity
y BMP antagonists (Uzgare et al., 1998). In animal caps, it
has been suggested that BMP antagonism may activate
MAPK which leads to smad1 down-regulation, but the
exact nature of this molecular chain of events is still
FIG. 7. Immunostaining of ectopically expressed MyoD protein fo
injected with 2 ng of in vitro transcribed XMyoD RNA. Two DLM
ach DLMZ pair was grown in the presence of 50 mM UO126, andunclear (Uzgare et al., 1998). Recent studies in Xenopus
Copyright © 2001 by Academic Press. All righthave shown that FGF/MAPK activity is required for poste-
rior neural patterning (Ribisi et al., 2000); however, the role
of MAPK in the initial induction of anterior-fated pan
neural tissue by BMP antagonists is still an open question.
Previous studies using Xenopus animal cap explants have
shown that active MEK1 can induce muscle actin expres-
sion (Umbhauer et al., 1995; LaBonne et al., 1995). In the
former study (Umbhauer et al., 1995; we used the same
ing MAPK pathway inhibition. Embryos at the one-cell stage were
plants were removed from 36 injected embryos. One explant from
other was grown as a control, without treatment.llow
Z exactivated MEK1 construct), exceedingly low levels of
s of reproduction in any form reserved.
t179Conversion of MyoD in Xenopusmuscle actin RNA were induced relative to the panmeso-
dermal XBra marker. These animal caps did not elongate
like activin-treated or DLMZ explants which differentiate
high muscle levels. The authors suggested that these ani-
mal caps differentiated to ventral mesoderm mimicking a
classic FGF treatment. In the latter study (LaBonne et al.,
1995), activated MEK1 induced high levels of muscle actin
expression in animal cap explants, even when compared to
other MAP kinase-activating reagents. In their study, acti-
vated MEK1 also stimulated higher levels of RSK/MAP
kinase activity in comparison to the other MAP kinase-
activating reagents. The authors suggested that the high
levels of MEK1 and resultant ERK activity might have
stimulated a more dorsal induction; however, there is no
report as to whether these explants typically elongated like
activin-treated animal cap or DLMZ explants. The authors
also suggested that high MEK1 levels may activate an
alternative non-MAP kinase target to induce muscle (La-
Bonne et al., 1995), although this has yet to be shown. In
our system, we examined the role of MAP kinase in
gastrula-stage VMZ and DLMZ explants which were al-
ready specified as mesoderm, thus circumventing the need
for the pregastrula MAP kinase activity required for early
mesoderm induction. Unlike blastula-stage animal cap ex-
plants, inhibition of MAP kinase signaling in VMZ or
DLMZ explants allows the uncoupling of mesoderm pat-
terning from the induction process.
We found that MAP kinase activity likely specifies
muscle by modulating XMyoD protein activity in the
DLMZ region. Ectopic expression of an activated MEK
protein did not induce muscle formation in VMZ explants.
However, the ectopic coexpression of XMyoD and activated
MEK proteins shifted the VMZ to muscle fates in the
absence of BMP antagonist treatment. Muscle differentia-
tion occurred at a much higher frequency in MEK and
XMyoD coinjected explants in comparison to explants
solely expressing ectopic XMyoD protein. These coinjected
VMZ explants elongated like DLMZ explants during neu-
rula stages, and expressed high levels of terminal differen-
tiation markers such as muscle-specific actin and the 12/
101 antigen. XMyoD protein and the MAP kinase pathway
synergize to specify muscle in the DLMZ region; thus, only
in the presence of MAPK signaling can XMyoD act as an
instructive differentiation factor.
To address the mode in which the MAPK pathway could
modulate XMyoD activity, we coexpressed XMyoD and
activated MEK protein along with a plasmid containing an
E-box-specific luciferase reporter gene. In VMZ explants,
MEK alone did not activate the reporter. However, in the
presence of MEK and XMyoD proteins, luciferase activity
was stimulated over fourfold versus XMyoD alone. In
explants coexpressing MEK and MyoD, we detected higher
XMyoD protein levels, although ectopic XMyoD RNA
levels were identical.
These results support a model in which, the combination
of BMP antagonism and the resultant induction of MAPK
activity converts XMyoD protein into an active differentia-
Copyright © 2001 by Academic Press. All rightion factor (Fig. 8). BMP antagonism fixes XMyoD transcrip-
tion in the DLMZ, in addition to inducing MAPK activity.
MAPK causes a further increase in XMyoD protein levels
that accumulate in nuclei and can activate muscle-specific
transcription (Fig. 8). Overall, it appears that BMP antago-
nism induces XMyoD by affecting transcriptional and post-
transcriptional events. We do not know whether the result-
ant increase in XMyoD transcriptional factor activity on an
E-box reporter gene is due to a direct change in the intrinsic
activity of the MyoD protein or just a result of its accumu-
lation in the nucleus. While these two possibilities are not
mutually exclusive, further experiments are being per-
formed to determine this point. However, it is clear that the
MAPK pathway alone cannot suffice to activate XMyoD
transcription in a VMZ explant, so BMP antagonism likely
acts in concert with MAPK activity to initially stimulate
XMyoD expression over a critical threshold. A similar
observation was also observed in C2 mouse myoblast cells
as they differentiated to myotubes in culture (Gredinger et
al., 1998). ERK activity increased as myoblasts underwent
terminal differentiation; in these cells, ERK activity also
induced increased MyoD transcriptional activity (Gredinger
et al., 1998).
The accumulation of MyoD protein in Xenopus explants
(this work) and in mammalian tissue culture cells (O.
Ostrovsky and E.B., unpublished results) indicates that
MAPK activity may decrease turnover of the MyoD protein.
The mechanism is unknown at present, but we speculate
that MAPK may stabilize MyoD by elevating levels of
p21-WAF1 (Sewing et al., 1997; Woods et al., 1997). MyoD
is phosphorylated at serine 200 by cdk/cyclin complexes,
which target the protein for rapid degradation and inactiva-
FIG. 8. Model of the role of MAPK signaling in muscle specifica-
tion in the DLMZ. The inhibition of BMP activity induces XMyoD
expression and increases MAPK activity in the DLMZ. MAPK
activity causes posttranscriptional modification of the XMyoD
protein, which converts MyoD into an instructive differentiation
factor.tion (Kitzmann et al., 1999). p21 inhibits these complexes
s of reproduction in any form reserved.
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180 Zetser, Frank, and Bengalfrom phosphorylating MyoD, and the dephosphorylated
protein is more stable (Kitzmann et al., 1999; Reynaud et
l., 1999).
During gastrulation, XMyoD transcripts and protein are
resent throughout the whole VMZ, but they do not suffice
o dorsalize the VMZ to muscle without antagonism of
MP signaling by the organizer. Our studies suggest that a
ajor role of the organizer may be to induce MAPK activity
n the DLMZ region. The lack of critical MAPK activity
evels in nonmuscle fated tissues may explain why XMyoD
xclusively triggers muscle differentiation in DLMZ meso-
erm during early amphibian development. This MAPK-
nduced posttranscriptional modification of XMyoD pro-
ein could lead to an up-regulation of MyoD-dependent
yoD transcription, in addition to increased transcription
f other MyoD target genes. Thus, perhaps as a result of
orsalization and autoactivation, MyoD could become a
otent differentiation factor that specifies muscle forma-
ion in the DLMZ region of the gastrulating Xenopus
mbryo.
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